ArticlePharmacological reports : PR2026

Unveiling novel transcriptomic prognostic biomarkers for specific breast cancer subtypes and treatment regimens.

Krittin Pitinanon et al.PubMed ↗Publisher ↗

No numbers read from the abstract.